Search for: "Doe v. Abbott Laboratories" Results 81 - 100 of 205
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2016, 12:30 pm
Wyeth Laboratories, 498 F.2d 1264, 1273-74 (5th Cir. 1974) (applying unavoidably unsafe standard without individualized assessment); Holland v. [read post]
21 May 2009, 10:03 am
  Regardless of whether we elect John McCain or Barack Obama, my hope is that we can get someone who actually knows a thing...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
29 Jun 2009, 2:59 pm
Docket: 08-645 Title: Abbott v. [read post]
2 Oct 2008, 12:36 pm
Abbott Laboratories, 447 F.3d 861, 867 (5th Cir. 2006), the court blew out this type of claim, finding the defendant's warning about high blood pressure sufficient and that there was no need to go further ant tell doctors about what high blood pressure itself can cause. [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules… [read post]
9 May 2012, 11:09 am by Seyfarth Shaw LLP
Co-authored by Richard Alfred and Jessica Schauer The Seventh Circuit ruled yesterday that pharmaceutical sales representatives (“PSRs”) for Eli Lilly & Co. and Abbott Laboratories Inc. are exempt from overtime under the Fair Labor Standards Act (“FLSA”) under the Administrative Exemption.  [read post]
29 Jun 2010, 6:01 pm by Duncan
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
30 Jun 2010, 5:52 am
USA (Patent Docs) Lexapro (Escitalopram) – US: Infosint’s infringement verdict over Lexapro overturned, patent ruled invalid (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
15 Sep 2011, 5:00 am by Bexis
Abbott Laboratories, 447 F.3d 861, 867 [read post]
3 Sep 2009, 6:44 pm
Abbott Laboratories, 297 F.3d 544 (7th Cir. 2002); United States v. [read post]
11 Dec 2009, 5:00 am
Abbott Laboratories, 607 P.2d 924 (Cal. 1980). [read post]
15 Jul 2010, 2:39 pm by Bexis
Abbott Laboratories, 607 P.2d 924 (Cal. 1980), a DES case. [read post]